Investment Insights News 22 December 2025

Micron Technology (MU) Stock After Hours Today (Dec. 22, 2025): What’s Driving the Move and What to Watch Before Tuesday’s Open

Micron Technology, Inc. (NASDAQ: MU) is ending Monday, December 22, 2025, on a strong note as the market heads into a holiday-shortened week. Shares closed up about 4% and ticked slightly higher in after-hours trading—keeping the memory-chip maker near its

23 December 2025

After Hours Trading·Investment Insights·Market Analysis·Stock Market

XRP Price Today (22.12.2025, 5:01 PM ET): XRP Holds Near $1.90 as ETF Inflows Clash With the $2 Wall

At 5:01 p.m. ET on December 22, 2025, XRP (Ripple) is trading around $1.90, down slightly on the session, with an intraday range of roughly $1.89–$1.94 as traders keep focusing on the stubborn $2.00 psychological ceiling. That “pinned below $2”

22 December 2025

Cryptocurrency·Investment Insights·Market Analysis·Price Updates·XRP News

Rivian (RIVN) Stock News Today: 52-Week High, Autonomy+ Rollout, and R2 Launch Hype Drive Fresh Upgrades (Dec. 22, 2025)

December 22, 2025 — Rivian Automotive, Inc. (NASDAQ: RIVN) is back in the spotlight as its stock trades near a one-year peak, powered by a fast-moving mix of autonomy headlines, a major software rollout, and rising optimism that the upcoming

22 December 2025

Company News·Electric Vehicles·Investment Insights·Stock Market·Technology Trends

Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Limited (NSE: INFY; BSE: INFY; NYSE: INFY) is back in the spotlight on December 22, 2025—this time for a rare mix of market microstructure drama and a legal overhang getting clearer. India-listed Infosys shares rose in Monday trading after

22 December 2025

Business Updates·Financial Forecasts·Investment Insights·Stock Market

Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics, Incorporated (NASDAQ: CYTK) surged on Monday, December 22, 2025, extending a sharp rally that followed the company’s first-ever U.S. drug approval. Shares traded around $69.68 in the session, up roughly 11% from the prior close, after reaching an intraday

22 December 2025

Analyst Ratings·Biotech News·FDA Approvals·Investment Insights·Stock Market

Firefly Aerospace Stock (NASDAQ: FLY) Jumps on Russell Index Addition: Today’s News, Analyst Forecasts, and Lawsuit Updates (Dec. 22, 2025)

Firefly Aerospace Inc. (NASDAQ: FLY) stock is back in the spotlight on December 22, 2025, with shares trading around $28 and posting a mid-session gain of roughly 14% after hitting an intraday high near $28.30 on elevated volume. Investing The

22 December 2025

Aerospace Industry·Company Analysis·Investment Insights·Legal Updates·Stock Market News

Netflix Stock (NFLX) Today: $25 Billion Financing, Warner Bros. Bid Battle, and Fresh Analyst Forecasts (Dec. 22, 2025)

Netflix, Inc. (NASDAQ: NFLX) stock is trading in a headline-driven tape on December 22, 2025, as investors weigh two fast-moving developments: a major refinancing move tied to Netflix’s proposed Warner Bros. Discovery transaction and a renewed challenge from Paramount Skydance

22 December 2025

Company News·Financial Analysis·Investment Insights·Stock Market·Streaming Services

Cisco (CSCO) Stock News, Forecasts, and Outlook: AI Networking Tailwinds vs. Security and Valuation Risks (Dec. 22, 2025)

Cisco Systems, Inc. (NASDAQ: CSCO) is ending 2025 with a story investors haven’t been able to ignore: the company is back near its highs, powered by accelerating AI-era networking demand and a broad push to fuse networking, security, and observability

22 December 2025

AI Technology·Investment Insights·Market Forecasts·Stock Analysis

Infosys Share Price Today: INFY Stock Jumps as NYSE ADR “Mystery Spike” and $17.5M McCamish Settlement Drive Fresh Focus

Dec. 22, 2025 — Infosys Limited (NSE: INFY | BSE: INFY | NYSE: INFY) is back in the spotlight on Monday after a rare combination of events: a sudden, outsized surge in its U.S.-listed ADRs that triggered trading halts, and

22 December 2025

Investment Insights·Stock Market

Hecla Mining Company Stock (NYSE: HL) in Focus on Dec. 22, 2025: S&P MidCap 400 Inclusion, Record Silver Prices, and 2026 Outlook

Dec. 22, 2025 — Hecla Mining Company (NYSE: HL) is starting the holiday-shortened week with two powerful tailwinds that tend to make mining stocks behave like they’ve had three espressos: index inclusion and surging metal prices. Today is the effective

22 December 2025

Company News·Financial Analysis·Investment Insights·Mining Industry·Stock Market

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18

22 December 2025

Analyst Forecasts·Biotech Stocks·Investment Insights·Mergers & Acquisitions·Stock Market News

Vedanta Demerger Update Dec 22, 2025: NCLT Approval, 1:1 Share Entitlement, Dividend Signals and Silver Rally at Hindustan Zinc

Vedanta’s long-awaited demerger is no longer just a boardroom plan—it has crossed its biggest legal hurdle and is now firmly in “execution mode.” The Mumbai bench of the National Company Law Tribunal (NCLT) has sanctioned Vedanta Ltd’s revised demerger scheme,

22 December 2025

Corporate Actions·Dividend Updates·Investment Insights·Stock Market News

Investment Insights News 22 December 2025 - 23 December 2025